MedPath

Study the effect of tdcs and treatment of mindfulness in substance abuse disorder

Not Applicable
Conditions
Substance use disorder.
Other psychoactive substance related disorders
Registration Number
IRCT20181013041327N1
Lead Sponsor
Cognitive Science and Technologies Council
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
80
Inclusion Criteria

Age range 18 to 21 years
Detection of substance abuse disorder based on DSM5 criteria
Be a boy

Exclusion Criteria

Taking psychiatric medications
Diagnosis of bipolar mood disorder or psychotic disorder based on DSM5 criteria
Intracranial implants
History of epilepsy and seizure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Executive Functions. Timepoint: Before the intervention, after the intervention and three weeks after the intervention. Method of measurement: Wisconsin card sorting test, N-Back Test, Go/ No Go Task, Balloon Analogue Risk Taking Task.;Emotional Disregulation. Timepoint: Before the intervention, after the intervention and three weeks after the intervention. Method of measurement: DERS.;Craving. Timepoint: Before the intervention, after the intervention and three weeks after the intervention. Method of measurement: Craving Questionnaire(Franken & etal).;Attention Bias in relation to the stimuli. Timepoint: Before the intervention, after the intervention and three weeks after the intervention. Method of measurement: Dot-Probe Task.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath